BIT Capital’s Cardiff Oncology CRDF Stock Holding History

BIT Capital’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-253,085	Closed	-$676K	–	118
2024 Q3	$676K	Sell	253,085 -42,433	-14%	-$100K	0.06%	80
2024 Q2	$656K	Buy	295,518 +59,339	+25%	+$224K	0.05%	91
2024 Q1	$1.26M	Buy	+236,179	New	+$628K	0.09%	82

Other funds holding CRDF

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT Capital's CRDF Position: Q4 2024 in Review

BIT Capital sold out of Cardiff Oncology (CRDF) in Q4 2024, closing a stake of 253,085 shares — an estimated $676K sold.

BIT Capital first reported a position in CRDF in Q1 2024 and held it in 3 quarters. The position peaked at $1.26M in Q1 2024. 117 funds tracked by Wall St. Rank hold CRDF as of Q4 2024.

BIT Capital reported no remaining Cardiff Oncology position as of Q4 2024 after selling out during the quarter.
BIT Capital sold 253,085 Cardiff Oncology shares in Q4 2024, an estimated $676K.
BIT Capital first reported a position in Cardiff Oncology in Q1 2024 and held it in 3 quarters.
BIT Capital's Cardiff Oncology position peaked at $1.26M in Q1 2024.
117 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2024.

Based on BIT Capital's 13F filing for Q4 2024, filed 12 Feb 2025.